Scientist III - Bioconjugation (ADC) Process Development
Exelixis
About this role
The Scientist III, Bioconjugation (ADC) Process Development at Exelixis will contribute to the company's Antibody Drug Conjugates (ADCs) technology platforms. This role focuses on developing scalable and robust downstream ADC processes and supporting technology transfer efforts for clinical GMP manufacturing of ADCs.
Skills
Qualifications
About Exelixis
exelixis.comExelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Recent company news
BitgetExelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
4 hours ago
Fierce PharmaExelixis aims to be a top-5 solid tumor drugmaker in the US: CEO
1 month ago
MarketBeatWhat is Zacks Research's Estimate for Exelixis Q3 Earnings?
3 days ago
Investing.com NigeriaExelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Business WireExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
2 weeks ago
About Exelixis
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Exelixis.
Salary
$90k – $128k
per year
More jobs at Exelixis
Similar Jobs
Sr. Scientist, Protein and Antibody Bioconjugation
Neurocrine Biosciences
Sr Scientist, Process Development
Gilead Sciences
Senior Scientist, Process Development - Bioconjugation
Dyne Therapeutics
Senior Scientist II, ADC/AOC Conjugation
AbbVie
Senior Scientist I, ADC/AOC Conjugation
AbbVie
Senior Scientist/Principal Scientist, ADC Biology & Biomarker Discovery
Hexagon Bio